[
  {
    "ts": null,
    "headline": "Regeneron Named to Dow Jones Sustainability World Index for Sixth Consecutive Year",
    "summary": "TARRYTOWN, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced its sixth consecutive inclusion in the Dow Jones Sustainability World Index (DJSI World) and fifth consecutive inclusion in the Dow Jones Sustainability North America Index (DJSI North America). These rankings highlight the company’s leadership in adopting responsible practices that drive business resilience and improve our world. The DJSI World Index is a leading benchmark for corpo",
    "url": "https://finnhub.io/api/news?id=c83cc833ae754a495994ff834e873a7ba0beb327729a3724fc21257f93a3550c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734384600,
      "headline": "Regeneron Named to Dow Jones Sustainability World Index for Sixth Consecutive Year",
      "id": 132016433,
      "image": "https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "TARRYTOWN, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced its sixth consecutive inclusion in the Dow Jones Sustainability World Index (DJSI World) and fifth consecutive inclusion in the Dow Jones Sustainability North America Index (DJSI North America). These rankings highlight the company’s leadership in adopting responsible practices that drive business resilience and improve our world. The DJSI World Index is a leading benchmark for corpo",
      "url": "https://finnhub.io/api/news?id=c83cc833ae754a495994ff834e873a7ba0beb327729a3724fc21257f93a3550c"
    }
  },
  {
    "ts": null,
    "headline": "Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases",
    "summary": "RHHBY wins approval for prefilled syringe of ophthalmology drug Vabysmo for three retinal conditions that can cause blindness.",
    "url": "https://finnhub.io/api/news?id=e960c6b5df2e8fb66d07be9fb1bfe08e887b496725a3def855cc73a2f39af7e8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734374400,
      "headline": "Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases",
      "id": 132016434,
      "image": "https://media.zenfs.com/en/zacks.com/045ba7ae9e660e2a91686804eef7ab55",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "RHHBY wins approval for prefilled syringe of ophthalmology drug Vabysmo for three retinal conditions that can cause blindness.",
      "url": "https://finnhub.io/api/news?id=e960c6b5df2e8fb66d07be9fb1bfe08e887b496725a3def855cc73a2f39af7e8"
    }
  }
]